Latest Insider Transactions at Aclaris Therapeutics, Inc. (ACRS)
This section provides a real-time view of insider transactions for Aclaris Therapeutics, Inc. (ACRS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aclaris Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aclaris Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
51,484
-1.03%
|
$205,936
$4.51 P/Share
|
|
Jun 24
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
63,240
-1.25%
|
$252,960
$4.52 P/Share
|
|
Jun 21
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
339,537
-6.28%
|
$1,358,148
$4.62 P/Share
|
|
May 10
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
180,565
-4.19%
|
$1,083,390
$6.05 P/Share
|
|
May 09
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
434,145
-9.04%
|
$2,604,870
$6.16 P/Share
|